Related references
Note: Only part of the references are listed.Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Dendritic cell-based nanovaccines for cancer immunotherapy
Leonie E. Paulis et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer
Kavita M. Dhodapkar et al.
ONCOIMMUNOLOGY (2013)
Decisions About Dendritic Cells: Past, Present, and Future
Ralph M. Steinman
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity
Takemasa Tsuji et al.
JOURNAL OF IMMUNOLOGY (2011)
Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody
Cheolho Cheong et al.
BLOOD (2010)
Division of labor, plasticity, and crosstalk between dendritic cell subsets
Bali Pulendran et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)